Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion type Assertion NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_head.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion description "[It has been shown that pharmacologic inhibition of the PI3K-AKT pathway results in feedback activation of other oncogenic signaling pathways, which likely will limit the clinical utilization of these inhibitors in cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_provenance.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion evidence source_evidence_literature NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_provenance.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion SIO_000772 24448243 NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_provenance.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion wasDerivedFrom befree-20150227 NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_provenance.
- NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_assertion wasGeneratedBy ECO_0000203 NP232744.RAhPXKYH7I1kk3SpZBPE9l-uIldPgdI483rHQSt7b1O_Y130_provenance.